ResDAC is currently experiencing a high volume of requests, which may delay response and processing times. We are working to address the backlog as quickly as possible and appreciate your patience.
ResDAC is currently experiencing a high volume of requests, which may delay response and processing times. We are working to address the backlog as quickly as possible and appreciate your patience.
Starting in 2020, Medicare Part D plan sponsors may limit formulary inclusion of a Part D drug to only certain FDA-approved indications. The corresponding standardized medical subject headings (MeSH) for this value appears in the variable called “MESH_CUI.” Both variables are included in the CMS created indication-based reference file in HPMS for plan sponsors to use for indication-based drug coverage.
The US National Library of Medicine maintains the standardized MeSH. MeSH is a hierarchically-organized terminology for indexing and cataloging of biomedical information. It is used for the indexing of PubMed and other NLM databases. Additional information is available on the NLM.NIH.gov website.